Aqua Bio Technology ASA (OSL:ABTEC)
Norway
· Delayed Price · Currency is NOK 7.64
+0.38 (5.21%)
At close: Mar 9, 2026
Aqua Bio Technology ASA Revenue
Aqua Bio Technology ASA had revenue of 6.88M NOK in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 101.51M, up 293.26% year-over-year. In the year 2024, Aqua Bio Technology ASA had annual revenue of 107.17M with 472.00% growth.
Revenue (ttm)
101.51M
Revenue Growth
+293.26%
P/S Ratio
0.24
Revenue / Employee
2.74M
Employees
37
Market Cap
24.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 107.17M | 88.44M | 472.00% |
| Dec 31, 2023 | 18.74M | 11.58M | 161.63% |
| Dec 31, 2022 | 7.16M | 5.19M | 262.49% |
| Dec 31, 2021 | 1.98M | 1.16M | 143.11% |
| Dec 31, 2020 | 812.63K | -482.56K | -37.26% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PCI Biotech Holding ASA | 4.69M |
| Arctic Bioscience AS | 45.90M |
| SoftOx Solutions AS | 13.59M |
| Zelluna ASA | 53.00K |
| Circio Holding ASA | 123.00K |
| Lytix Biopharma AS | 377.00K |
| Nykode Therapeutics AS | 4.57M |
| ArcticZymes Technologies ASA | 118.21M |